BioRestorative Therapies (BRTXQ) Stock Price, News & Analysis

Company Overview

BioRestorative Therapies, Inc. is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc., which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.

The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials. These products employ a network of biocompatible microfibers intended to mimic the extracellular matrix, thereby providing a structural framework for host cells and delivered therapeutic agents. Although the company’s scaffold candidates are in early‐stage development and preclinical evaluation, BioRestorative is pursuing regulatory pathways aimed at establishing these materials as off‐the‐shelf or autologous cell‐loaded treatments for patients with limited wound‐healing options.

BioRestorative holds multiple U.S. and international patents covering its scaffold design, manufacturing methods and potential combination uses with cells or growth factors. Through collaborations with research institutions and contract development and manufacturing organizations, the company is advancing its technology toward Investigational New Drug (IND) applications. Headquartered in Deerfield Beach, Florida, BioRestorative currently serves the U.S. market while evaluating opportunities for broader geographic expansion as its product candidates progress through regulatory review.

Key Stats

• Today's Range: $0.22 to $0.24
• 50-Day Range: $0.20 to $0.31
• 52-Week Range: $0.00 to $0.06
• Volume: 842,675 shs
• Average Volume: 62.17 million shs
• Market Capitalization: $382.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BRTXQ Stock Analysis - Frequently Asked Questions

How have BRTXQ shares performed this year?

BioRestorative Therapies' stock was trading at $1.1750 at the beginning of the year. Since then, BRTXQ stock has decreased by 80.1% and is now trading at $0.2333.

How do I buy shares of BioRestorative Therapies?

Shares of BRTXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Miscellaneous Health & Allied Services
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:BRTXQ
• CIK: 1505497
• Web: www.biorestorative.com
• Phone: 631-760-8100
• Fax: N/A
• Employees: 7
• Year Founded: 1997

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $110 thousand
• Price / Sales: 3,476.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.68) per share
• Price / Book: -0.34

Miscellaneous

• Outstanding Shares: 1,639,626,000
• Free Float: N/A
• Market Cap: $382.44 million
• Optionable: Not Optionable
• Beta: 102.36